POGK
geneOn this page
Also known as KIAA15131LST003BASS2KRBOX2
Summary
POGK (pogo transposable element derived with KRAB domain, HGNC:18800) is a protein-coding gene on chromosome 1q24.1, encoding Pogo transposable element with KRAB domain (Q9P215).
The exact function of the protein encoded by this gene is not known. However, this gene product contains a KRAB domain (which is involved in protein-protein interactions) at the N-terminus, and a transposase domain at the C-terminus, suggesting that it may belong to the family of DNA-mediated transposons in human.
Source: NCBI Gene 57645 — RefSeq curated summary.
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 67 total
- MANE Select transcript:
NM_017542
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18800 |
| Approved symbol | POGK |
| Name | pogo transposable element derived with KRAB domain |
| Location | 1q24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA15131, LST003, BASS2, KRBOX2 |
| Ensembl gene | ENSG00000143157 |
| Ensembl biotype | protein_coding |
| OMIM | 620039 |
| Entrez | 57645 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 19 protein_coding
ENST00000367875, ENST00000367876, ENST00000449930, ENST00000898750, ENST00000898751, ENST00000898752, ENST00000898753, ENST00000898754, ENST00000928419, ENST00000928420, ENST00000928421, ENST00000928422, ENST00000928423, ENST00000928424, ENST00000928425, ENST00000928426, ENST00000928427, ENST00000972109, ENST00000972110
RefSeq mRNA: 2 — MANE Select: NM_017542
NM_001314014, NM_017542
CCDS: CCDS1254
Canonical transcript exons
ENST00000367876 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000958421 | 166846612 | 166846738 |
| ENSE00000958422 | 166847494 | 166847592 |
| ENSE00000958423 | 166848938 | 166850423 |
| ENSE00000958424 | 166852585 | 166856359 |
| ENSE00001445829 | 166839475 | 166839604 |
| ENSE00003571197 | 166840955 | 166841088 |
Expression profiles
Bgee: expression breadth ubiquitous, 274 present calls, max score 92.92.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 27.8835 / max 475.9939, expressed in 1811 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 6412 | 26.2106 | 1808 |
| 6411 | 1.6728 | 1150 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| Brodmann (1909) area 46 | UBERON:0006483 | 92.92 | gold quality |
| cortical plate | UBERON:0005343 | 92.83 | gold quality |
| ganglionic eminence | UBERON:0004023 | 92.36 | gold quality |
| medial globus pallidus | UBERON:0002477 | 92.12 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 91.74 | gold quality |
| globus pallidus | UBERON:0001875 | 91.72 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 91.72 | gold quality |
| corpus callosum | UBERON:0002336 | 91.57 | gold quality |
| postcentral gyrus | UBERON:0002581 | 91.24 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 90.61 | gold quality |
| parietal lobe | UBERON:0001872 | 90.53 | gold quality |
| spinal cord | UBERON:0002240 | 90.53 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 90.32 | gold quality |
| embryo | UBERON:0000922 | 90.01 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 89.87 | gold quality |
| ventricular zone | UBERON:0003053 | 89.85 | gold quality |
| adult organism | UBERON:0007023 | 89.70 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 89.60 | gold quality |
| upper leg skin | UBERON:0004262 | 89.52 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 89.22 | gold quality |
| ventral tegmental area | UBERON:0002691 | 88.98 | gold quality |
| lower lobe of lung | UBERON:0008949 | 88.76 | gold quality |
| entorhinal cortex | UBERON:0002728 | 88.68 | gold quality |
| pons | UBERON:0000988 | 88.54 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 88.42 | gold quality |
| medulla oblongata | UBERON:0001896 | 88.37 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 88.33 | gold quality |
| amygdala | UBERON:0001876 | 88.22 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 88.15 | gold quality |
| temporal lobe | UBERON:0001871 | 88.13 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.22 |
| E-MTAB-7303 | no | 665.93 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2560.1 | POGK | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605320
miRNA regulators (miRDB)
169 targeting POGK, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-499A-5P | 99.98 | 70.79 | 1323 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-22-3P | 99.93 | 68.13 | 917 |
| HSA-MIR-552-5P | 99.93 | 68.56 | 1583 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Pogk | ENSMUSG00000040596 |
| rattus_norvegicus | Pogk | ENSRNOG00000032058 |
Paralogs (12): CENPB (ENSG00000125817), TIGD7 (ENSG00000140993), POGZ (ENSG00000143442), TIGD6 (ENSG00000164296), TIGD4 (ENSG00000169989), TIGD3 (ENSG00000173825), TIGD5 (ENSG00000179886), TIGD2 (ENSG00000180346), JRKL (ENSG00000183340), TIGD1 (ENSG00000221944), JRK (ENSG00000234616), (ENSG00000293642)
Protein
Protein identifiers
Pogo transposable element with KRAB domain — Q9P215 (reviewed: Q9P215)
All UniProt accessions (2): Q9P215, Q5TIJ2
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
RefSeq proteins (2): NP_001300943, NP_060012* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR003655 | aKRAB | Domain |
| IPR004875 | DDE_SF_endonuclease_dom | Domain |
| IPR006600 | HTH_CenpB_DNA-bd_dom | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR018586 | Brinker_DNA-bd | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR050863 | CenT-Element_Derived | Family |
Pfam: PF01352, PF03184, PF03221, PF09607
UniProt features (11 total): domain 3, region of interest 3, cross-link 2, chain 1, coiled-coil region 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9P215-F1 | 68.59 | 0.26 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 384, 13
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 145 (showing top):
CREL_01, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, USF_C, MYCMAX_01, USF_01, AAAGACA_MIR511, ACATTCC_MIR1_MIR206, BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP, VDR_Q3, USF_02, GCM_CALM1, CCCNNGGGAR_OLF1_01, TGGAAA_NFAT_Q4_01, CAIRO_LIVER_DEVELOPMENT_UP, AACATTC_MIR4093P
GO Biological Process (1): regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (3): DNA binding (GO:0003677), nucleic acid binding (GO:0003676), protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), nucleoplasm (GO:0005654)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| nucleic acid binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
672 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| POGK | TIGD5 | Q53EQ6 | 572 |
| POGK | TIGD7 | Q6NT04 | 570 |
| POGK | TIGD3 | Q6B0B8 | 542 |
| POGK | NAIF1 | Q69YI7 | 537 |
| POGK | PGBD2 | Q6P3X8 | 524 |
| POGK | ME2 | P23368 | 517 |
| POGK | LRRC52 | Q8N7C0 | 513 |
| POGK | ILDR2 | Q71H61 | 511 |
| POGK | EVI5L | Q96CN4 | 503 |
| POGK | TMCO1 | Q9UM00 | 503 |
| POGK | ZBED8 | Q8IZ13 | 498 |
| POGK | JRKL | Q9Y4A0 | 496 |
| POGK | PGBD1 | Q96JS3 | 490 |
| POGK | PGBD5 | Q8N414 | 481 |
| POGK | ILDR1 | Q86SU0 | 480 |
IntAct
33 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ARPC1B | ARPC2 | psi-mi:“MI:0914”(association) | 0.920 |
| RFXANK | RFXAP | psi-mi:“MI:0914”(association) | 0.780 |
| TCEAL1 | CHEK1 | psi-mi:“MI:0914”(association) | 0.530 |
| CCNDBP1 | JUN | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| POGK | HSP90AB1 | psi-mi:“MI:0915”(physical association) | 0.520 |
| Trim28 | FTH1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| UCHL3 | POGK | psi-mi:“MI:0915”(physical association) | 0.370 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| TRIM11 | BTN3A3 | psi-mi:“MI:0914”(association) | 0.350 |
| WEE1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| EEF1AKMT2 | IFT56 | psi-mi:“MI:0914”(association) | 0.350 |
| S100P | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| PTGES3 | SBNO1 | psi-mi:“MI:0914”(association) | 0.350 |
| PRKY | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| TRIM11 | RABGAP1L | psi-mi:“MI:0914”(association) | 0.350 |
| NAA11 | DVL2 | psi-mi:“MI:0914”(association) | 0.350 |
| ARL2BP | GNPAT | psi-mi:“MI:0914”(association) | 0.350 |
| NPAS1 | CIBAR1 | psi-mi:“MI:0914”(association) | 0.350 |
| PLEKHG7 | MROH6 | psi-mi:“MI:0914”(association) | 0.350 |
| UBXN6 | ZSWIM8 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF44 | ZNF195 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (43): POGK (Affinity Capture-MS), POGK (Affinity Capture-MS), POGK (Affinity Capture-MS), POGK (Affinity Capture-MS), POGK (Affinity Capture-MS), POGK (Affinity Capture-MS), POGK (Affinity Capture-MS), POGK (Affinity Capture-MS), POGK (Affinity Capture-MS), POGK (Affinity Capture-MS), POGK (Proximity Label-MS), POGK (Affinity Capture-MS), POGK (Affinity Capture-MS), POGK (Affinity Capture-MS), POGK (Affinity Capture-MS)
ESM2 similar proteins: A3KPE8, A4IFA3, A8MT19, B2RD01, B2RRL2, E1BB03, G5ED66, O14423, O16810, O60108, O75564, O96006, P20913, P20914, P39428, P49777, P54789, P55968, Q0E2Q3, Q0VBL1, Q13415, Q17RP2, Q28DG7, Q2HEW6, Q4V3E2, Q4W5G0, Q58DC8, Q5SMU7, Q5SVZ6, Q5U2X2, Q60976, Q6NT04, Q6R2W3, Q80TC5, Q80Z32, Q8BUZ3, Q8GT06, Q8GYE8, Q8IY51, Q8L727
Diamond homologs: A6NFI3, A6NM28, A6NNF4, A6QLU5, A8MQ14, A8MUV8, B4DU55, B4DX44, E9Q8G5, O60290, O75290, O75467, O94892, O95780, P0DPD5, P17014, P17031, P17032, P17097, P17098, P21506, P51523, P59923, Q02525, Q03936, Q05481, Q06732, Q08DG8, Q14586, Q14590, Q15928, Q16587, Q2M218, Q2TL60, Q3B7M4, Q3KQV3, Q3SXZ3, Q49AA0, Q4R6C2, Q4R8H9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
67 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 61 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1523 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:166840954:GAGAT:G | acceptor_gain | 1.0000 |
| 1:166841058:GAAA:G | donor_gain | 1.0000 |
| 1:166841059:A:T | donor_gain | 1.0000 |
| 1:166841062:G:GG | donor_gain | 1.0000 |
| 1:166841084:GATGG:G | donor_gain | 1.0000 |
| 1:166841087:GG:G | donor_gain | 1.0000 |
| 1:166841088:GG:G | donor_gain | 1.0000 |
| 1:166841091:AA:A | donor_loss | 1.0000 |
| 1:166846699:G:GT | donor_gain | 1.0000 |
| 1:166846699:G:T | donor_gain | 1.0000 |
| 1:166846710:G:GT | donor_gain | 1.0000 |
| 1:166858116:TACCT:T | donor_loss | 1.0000 |
| 1:166858117:A:AC | donor_gain | 1.0000 |
| 1:166858118:C:CC | donor_gain | 1.0000 |
| 1:166858118:C:CT | donor_loss | 1.0000 |
| 1:166858118:CCTG:C | donor_gain | 1.0000 |
| 1:166858279:GGG:G | acceptor_gain | 1.0000 |
| 1:166858282:C:CC | acceptor_gain | 1.0000 |
| 1:166860181:TTTA:T | donor_loss | 1.0000 |
| 1:166860182:TTAC:T | donor_loss | 1.0000 |
| 1:166860183:TACC:T | donor_loss | 1.0000 |
| 1:166860184:A:AT | donor_loss | 1.0000 |
| 1:166860185:CCTTT:C | donor_gain | 1.0000 |
| 1:166860211:C:CT | donor_gain | 1.0000 |
| 1:166860212:T:TT | donor_gain | 1.0000 |
| 1:166860333:TGATT:T | acceptor_gain | 1.0000 |
| 1:166860334:GATT:G | acceptor_gain | 1.0000 |
| 1:166860335:ATT:A | acceptor_gain | 1.0000 |
| 1:166860336:TT:T | acceptor_gain | 1.0000 |
| 1:166860336:TTC:T | acceptor_loss | 1.0000 |
AlphaMissense
4041 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:166849189:T:C | F204L | 1.000 |
| 1:166849190:T:C | F204S | 1.000 |
| 1:166849191:C:A | F204L | 1.000 |
| 1:166849191:C:G | F204L | 1.000 |
| 1:166849192:A:C | K205Q | 1.000 |
| 1:166849192:A:G | K205E | 1.000 |
| 1:166849194:G:C | K205N | 1.000 |
| 1:166849194:G:T | K205N | 1.000 |
| 1:166849196:T:C | L206P | 1.000 |
| 1:166849202:T:A | V208E | 1.000 |
| 1:166849213:G:C | A212P | 1.000 |
| 1:166849214:C:A | A212D | 1.000 |
| 1:166849230:C:A | N217K | 1.000 |
| 1:166849230:C:G | N217K | 1.000 |
| 1:166849238:C:A | A220D | 1.000 |
| 1:166849240:G:C | A221P | 1.000 |
| 1:166849241:C:A | A221D | 1.000 |
| 1:166849249:T:A | F224I | 1.000 |
| 1:166849249:T:C | F224L | 1.000 |
| 1:166849251:T:A | F224L | 1.000 |
| 1:166849251:T:G | F224L | 1.000 |
| 1:166849261:G:A | E228K | 1.000 |
| 1:166849262:A:T | E228V | 1.000 |
| 1:166849270:G:T | V231F | 1.000 |
| 1:166849271:T:A | V231D | 1.000 |
| 1:166849274:G:C | R232P | 1.000 |
| 1:166849279:T:A | W234R | 1.000 |
| 1:166849279:T:C | W234R | 1.000 |
| 1:166849280:G:C | W234S | 1.000 |
| 1:166849281:G:C | W234C | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000034282 (1:166854383 T>C), RS1000298954 (1:166852598 G>C,T), RS1000345677 (1:166850236 G>A), RS1000845448 (1:166844644 C>G,T), RS1000875069 (1:166839169 A>G,T), RS1000947963 (1:166837655 G>A,C,T), RS1001074457 (1:166844985 G>A,T), RS1001226331 (1:166845535 G>A,T), RS1001274781 (1:166844387 G>C), RS1001302778 (1:166839269 C>A,T), RS1001332145 (1:166838988 G>A), RS1001594104 (1:166845929 C>T), RS1001626465 (1:166839623 GGGC>G,GGGCGGC,GGGCGGCGGC), RS1002002417 (1:166838697 T>A,C), RS1002233386 (1:166838282 C>T)
Disease associations
OMIM: gene MIM:620039 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002681_2 | Post-traumatic stress disorder | 3.000000e-06 |
| GCST010697_48 | Cortical surface area (min-P) | 3.000000e-13 |
| GCST010698_42 | Subcortical volume (min-P) | 8.000000e-12 |
| GCST010699_55 | Brain morphology (min-P) | 2.000000e-40 |
| GCST010700_39 | Cortical thickness (MOSTest) | 4.000000e-08 |
| GCST010701_100 | Cortical surface area (MOSTest) | 1.000000e-12 |
| GCST010702_40 | Subcortical volume (MOSTest) | 2.000000e-10 |
| GCST010703_26 | Brain morphology (MOSTest) | 5.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 3 |
| Formaldehyde | decreases expression | 2 |
| Valproic Acid | affects expression, decreases expression | 2 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 2 |
| TAK-243 | decreases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | affects expression | 1 |
| arsenite | decreases reaction, affects binding | 1 |
| sodium arsenite | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| ICG 001 | increases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Lead | decreases expression | 1 |
| Mercury | affects expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Rotenone | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | increases expression, decreases methylation | 1 |
Cellosaurus cell lines
5 cell lines: 5 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2BC | Abcam HeLa POGK KO | Cancer cell line | Female |
| CVCL_TE81 | HAP1 POGK (-) 1 | Cancer cell line | Male |
| CVCL_TE82 | HAP1 POGK (-) 2 | Cancer cell line | Male |
| CVCL_TE83 | HAP1 POGK (-) 3 | Cancer cell line | Male |
| CVCL_TE84 | HAP1 POGK (-) 4 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): post-traumatic stress disorder